Search results
Results from the WOW.Com Content Network
Akebia Therapeutics Inc (NASDAQ: AKBA) and Otsuka Holdings (OTC: OTSKY) separately announced to call for licensing and co-development agreement for vadadustat. Otsuka sent a written notice to ...
In 2011, Astex Therapeutics Limited and SuperGen, Inc. (US) merged. [10] Following the acquisition, SuperGen, Inc. changed its name to Astex Pharmaceuticals, Inc., and began trading under the ticker symbol ASTX on NASDAQ. [11] The combined Astex entities were subsequently acquired by Otsuka Pharmaceutical in October 2013 for around USD $900 ...
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
It recently yielded around 3.5% and it held stock in roughly 100 companies. Buying into a good dividend-focused ETF can save you from having to research and pick individual dividend payers, hoping ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Otsuka Pharmaceutical Co., Ltd. (大塚製薬株式会社, Ōtsuka Seiyaku Kabushiki-gaisha) (TYO: 4578), abbreviated OPC, is a pharmaceutical company headquartered in Tokyo, Osaka and Naruto, Japan. The company was established August 10, 1964.
Otsuka will pay $800 million to Jnana shareholders along with up to $325 million in development and regulatory milestones, the Japanese Japan's Otsuka Pharma to pay up to $1.1 billion to acquire ...
Why Intellia Therapeutics Stock Plummeted by 20% Today. Eric Volkman, The Motley Fool. October 24, 2024 at 7:22 PM. Thursday was hardly a good day to be a shareholder of Intellia Therapeutics ...